CEREBRAL PERFUSION IMAGING EVALUATES PHARMACOLOGICAL TREATMENT OF UNILATERAL MOYAMOYA-DISEASE
Citation
M. Kuroki et al., CEREBRAL PERFUSION IMAGING EVALUATES PHARMACOLOGICAL TREATMENT OF UNILATERAL MOYAMOYA-DISEASE, The Journal of nuclear medicine, 37(1), 1996, pp. 84-86
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
SICI code
0161-5505(1996)37:1<84:CPIEPT>2.0.ZU;2-J
Abstract
Unilateral Moyamoya disease presents as unilateral stenosis or obstruc
tion of the supraclinoid internal carotid artery, which causes cerebra
l hypoperfusion resulting in seizures or TIA-like attacks. In severe c
ases, surgical treatment is performed with superficial temporal artery
-middle cerebral artery anastomosis, In mild cases, conservative manag
ement is the treatment of choice, Flunarizine is a calcium ion anti-bl
ocking agent, whose primary effect is that the cerebral vessels have b
een used for the treatment of postcerebrovascular disorders. Recently,
it has been suggested that flunarizine could be used to treat Moyamoy
a disease. This report documents the efficacy of flunarizine to improv
e regional cerebral perfusion in Moyamoya disease.